Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy ChemoCentryx stock
Learn how to easily invest in ChemoCentryx stock.
ChemoCentryx Inc is a biotechnology business based in the US. ChemoCentryx shares (CCXI) are listed on the NASDAQ and all prices are listed in US Dollars. ChemoCentryx employs 178 staff and has a trailing 12-month revenue of around $37.3 million.
How to buy shares in ChemoCentryx
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CCXI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
ChemoCentryx stock price (NASDAQ: CCXI)Use our graph to track the performance of CCXI stocks over time.
ChemoCentryx shares at a glance
|Latest market close||$51.82|
|52-week range||$14.95 - $51.85|
|50-day moving average||$46.19|
|200-day moving average||$30.92|
|Wall St. target price||$52.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.01|
Buy ChemoCentryx shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ChemoCentryx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ChemoCentryx price performance over time
|1 week (2022-09-27)||0.35%|
|1 month (2022-09-02)||0.78%|
|3 months (2022-07-01)||93.65%|
|6 months (2022-04-01)||93.72%|
|1 year (2021-10-04)||179.96%|
|2 years (2020-10-02)||-3.48%|
|3 years (2019-10-04)||623.74%|
|5 years (2017-10-04)||516.17%|
|Revenue TTM||$37.3 million|
|Gross profit TTM||$-51,068,000|
|Return on assets TTM||-18.55%|
|Return on equity TTM||-46.96%|
|Market capitalisation||$3.7 billion|
TTM: trailing 12 months
ChemoCentryx share dividends
We're not expecting ChemoCentryx to pay a dividend over the next 12 months.
ChemoCentryx share price volatility
Over the last 12 months, ChemoCentryx's shares have ranged in value from as little as $14.95 up to $51.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ChemoCentryx's is 1.2353. This would suggest that ChemoCentryx's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
ChemoCentryx, Inc. , a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc.
ChemoCentryx in the news
Why Is Ionis Pharmaceuticals (IONS) Down 5.8% Since Last Earnings Report?
Why Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?
7 Dow Stocks With Superior Fundamentals
Frequently asked questionsWhat percentage of ChemoCentryx is owned by insiders or institutions?
Currently 12.008% of ChemoCentryx shares are held by insiders and 83.56% by institutions. How many people work for ChemoCentryx?
Latest data suggests 178 work at ChemoCentryx. When does the fiscal year end for ChemoCentryx?
ChemoCentryx's fiscal year ends in December. Where is ChemoCentryx based?
ChemoCentryx's address is: 835 Industrial Avenue, San Carlos, CA, United States, 94070 What is ChemoCentryx's ISIN number?
ChemoCentryx's international securities identification number is: US16383L1061 What is ChemoCentryx's CUSIP number?
ChemoCentryx's Committee on Uniform Securities Identification Procedures number is: 16383L106
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert